
Updated
Iran's National Cancer Institute, affiliated with the Academic Center for Education, Culture, and Research (ACECR), plans an international structure linking Islamic nations in nano-medicine and cancer research, aiming to become a leading nano-oncology reference hub. Tehran Times, an Iranian state-aligned outlet, reported the plan, and no timeline or funding was given. The institute joined the Inter-Islamic Network on Nanotechnology (INN) in November, opening cooperation with its 57 member states, according to the ACECR website as cited by Tehran Times. ACECR Deputy for Research and Technology Zahra Sheikhi said the plans include a nano-oncology innovation center, a research consortium with universities in member states such as Turkey, Malaysia, Pakistan and Egypt, a technology and patent observatory, a shared database, and a joint venture capital fund drawing on foreign investors, particularly from North Africa and the Persian Gulf. Tehran Times also reported that the institute makes nanotechnology products such as drug nanocarriers, nanocurcumin and nanobiosensors, and that the plan aims to widen their markets in Islamic nations. Separately, the Motamed Cancer Institute was elevated to the National Cancer Institute in October 2025, and construction of a 15-storey cancer innovation tower in Tehran was announced, with part of its funding secured.